Suppr超能文献

玻璃酸钠治疗白内障术后干眼的 Meta 分析。

Sodium hyaluronate in the treatment of dry eye after cataract surgery: a meta-analysis.

机构信息

Department of Ophthalmology, Chongqing Aier Eye Hospital, Chongqing 400000, China.

Department of Ophthalmology, Chongqing Aier Mega Eye Hospital, Chongqing 400060, China.

出版信息

Ann Palliat Med. 2020 May;9(3):927-939. doi: 10.21037/apm-20-695. Epub 2020 May 12.

Abstract

BACKGROUND

The incidence of dry eye is high after a cataract surgery. However, the clinical efficacy of sodium hyaluronate combined with conventional eye drops for dry eye after cataract surgery remains unclear. The currently available studies were based on small sample sizes, and no systematic review on this topic has been conducted. Thus, a meta-analysis was performed to systematically and accurately evaluate the clinical value of sodium hyaluronate in the treatment of dry eye after cataract surgery.

METHODS

English-language databases including PubMed, Cochrane, and Web of Science, and Chineselanguage databases including (CNKI), Wanfang Database, and CQVIP were systematically searched for relevant articles published up to December 31, 2019. The pooled effect size of qualitative data was evaluated with relative risk (RR) and 95% confidence interval (CI), and the overall effect of the quantitative data was estimated by using weighted mean difference (WMD) or standard mean difference (SMD) and 95% CI. Randomized controlled clinical trials concerning the use of sodium hyaluronate combined with conventional treatment for dry eye after cataract surgery were included. The quality of the included literature was evaluated by RevMan5.3 software, and the rest of the statistical data were analyzed using the "meta" package of the R3.5.1 software.

RESULTS

A total of 24 articles including 2,177 eyes (1,088 eyes in the combination group and 1089 eyes in the control group) were included. Twelve articles reported the total effective rate after 1 month of treatment (I2 =71%), and the random effects model was used to estimate RR. The total effective rate in the combination group was 1.33 times that of the control group (95% CI: 1.21, 1.47). Ten articles reported the dry eye symptom score after 1 month of treatment (I2 =92%). The SMD was estimated using the random effects model. The dry eye symptom score in the combination group was significantly lower than that in the control group, with an SMD of -2.98 (95% CI: -3.69, -2.27). Seventeen articles reported the tear film break-up time (BUT) after 1 month of treatment. As shown in the random effects model, BUT was significantly longer in the combination group than in the control group, with an MD of 2.06 (95% CI: 1.63, 2.49). Sixteen articles described the scores of a fluorescein (FL) eye stain test after 1 month of treatment. As shown in the random effects model, FL score was significantly lower in the combination group than in the control group, with an SMD of -2.52 (95% CI: -3.23, -1.81). Eight articles reported the results of Schirmer I test (SIt) after 1 month of treatment. As estimated by the random effects model, the wetting length in SIt was significantly higher in the combination group than in the control group, with an MD of 1.50 (95% CI: 0.53, 2.48). In the elderly population, BUT was significantly higher in the combined group than in the control group, with an MD of 2.97 (95%CI: 2.47, 3.47); however, the FL score and SIt showed no such significant difference.

CONCLUSIONS

For the patients with dry eye after cataract surgery, sodium hyaluronate on the basis of conventional anti-inflammatory treatment is highly effective as it can improve the dry eye symptom score and the results of 3 tests for dry eye. However, high-quality studies are warranted to further investigate the safety of sodium hyaluronate.

摘要

背景

白内障手术后干眼症的发病率很高。然而,玻璃酸钠联合常规滴眼液治疗白内障术后干眼症的临床疗效尚不清楚。目前的研究基于小样本量,尚未对此主题进行系统评价。因此,进行了一项荟萃分析,以系统和准确地评估玻璃酸钠治疗白内障术后干眼症的临床价值。

方法

系统检索了 PubMed、Cochrane 和 Web of Science 等英文数据库以及中国的(CNKI)、万方数据库和 CQVIP 等中文数据库,检索截至 2019 年 12 月 31 日发表的相关文章。定性数据的汇总效应大小用相对风险(RR)和 95%置信区间(CI)评估,定量数据的总体效应用加权均数差(WMD)或标准均数差(SMD)和 95%CI 估计。纳入的文献质量评价采用 RevMan5.3 软件,其余统计数据采用 R3.5.1 软件的“meta”包进行分析。

结果

共纳入 24 篇文章,涉及 2177 只眼(联合组 1088 只眼,对照组 1089 只眼)。12 篇文章报道了治疗 1 个月后的总有效率(I2=71%),采用随机效应模型估计 RR。联合组的总有效率是对照组的 1.33 倍(95%CI:1.21,1.47)。10 篇文章报道了治疗 1 个月后的干眼症状评分。采用随机效应模型估计 SMD。联合组的干眼症状评分明显低于对照组,SMD 为-2.98(95%CI:-3.69,-2.27)。17 篇文章报道了治疗 1 个月后的泪膜破裂时间(BUT)。随机效应模型显示,联合组的 BUT 明显长于对照组,MD 为 2.06(95%CI:1.63,2.49)。16 篇文章描述了治疗 1 个月后荧光素(FL)眼染色试验的评分。随机效应模型显示,联合组的 FL 评分明显低于对照组,SMD 为-2.52(95%CI:-3.23,-1.81)。8 篇文章报道了治疗 1 个月后的 Schirmer I 试验(SIt)结果。随机效应模型估计,联合组的湿长明显高于对照组,MD 为 1.50(95%CI:0.53,2.48)。在老年人群中,联合组的 BUT 明显高于对照组,MD 为 2.97(95%CI:2.47,3.47);然而,FL 评分和 SIt 没有显著差异。

结论

对于白内障术后干眼症患者,玻璃酸钠联合常规抗炎治疗效果显著,可改善干眼症状评分和 3 项干眼检查结果。然而,需要高质量的研究进一步探讨玻璃酸钠的安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验